India Globalization Capital Inc (IGC)

India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that the United States Patent and Trademark Office (“USPTO”) issued a patent (#11,351,152) to the Company titled “Method and Composition for Treating Seizure Disorders.”

On May 10, 2022, a License Agreement (the “License Agreement”) was entered into by and between Jawaharlal Nehru Centre for Advanced Scientific Research (“JNCASR”), Bengaluru (“Licensor”) and Hamsa Biopharma India Private Limited, Delhi (“Licensee”). As a result of the License Agreement there was a transfer of rights of a proprietary technology and know-how of certain patents and patent filings relating to small molecule inhibitors with a naphthalene monoamide scaffold (“NMI Compounds”). The NMI Compounds, to which we have the rights to, can potentially, but there can be no assurance thereof, ameliorate in vitro and in vivo amyloid induced neurotoxicity, which are prospective candidates to treat certain nervous system disorders in humans, including Alzheimer’s Disease; and/or may have other pharmacological or non-pharmacological benefits and applications. The JNCASR is an autonomous institution under the Department of Science and Technology, Government of India, an institution deeme

The House of Representatives intends to vote on a bill to federally legalize cannabis for the second time in history next week, congressional leadership confirmed.The House will take up the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act is poised to end up on the House floor next week, reported Marijuana Moment.The legislation, which would remove cannabis from the list of federally controlled substances and promote social equity in the industry had already cleared the Judiciary Committee this session and will now officially head to the House floor for a vote.The following cannabis stocks moved amid the legalization report:

Buoni i volumi in ah

Lascia i dinosauri della finanza alle loro analisi fallimentari, prova a cercare su google 'Markt Miracle Advisors' e potrai conoscere le posizioni degli investitori istituzionali per ogni titolo

Comunque è un po’ di giorni che si muove…qualcosa bolle in pentola

Cosa succede?

chissà se volerà anche oggi

Oggi vola !

India Globalization Capital (NYSE:IGC) announces the completion of its Phase 1 trial on IGC's cannabis-based investigational new drug, IGC-AD1, for patients suffering from Alzheimer's disease (AD). IGC shares surged 22% after-hours.